Enanta Pharmaceuticals, Inc (ENTA) is a publicly traded Healthcare sector company. As of May 21, 2026, ENTA trades at $9.55 with a market cap of $391.10M and a P/E ratio of -5.28. ENTA moved -0.87% today. Year to date, ENTA is -2.16%; over the trailing twelve months it is +124.22%. Its 52-week range spans $4.09 to $17.15. Analyst consensus is strong buy with an average price target of $19.67. Rallies surfaces ENTA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Enanta Pharmaceuticals, Inc (ENTA) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ENTA moved -0.87% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $9.55 |
| Market Cap | $391.10M |
| P/E Ratio | -5.28 |
| EPS | $-2.60 |
| Dividend Yield | 0.00% |
| 52-Week High | $17.15 |
| 52-Week Low | $4.09 |
| Volume | 2 |
| Avg Volume | 0 |
| Revenue (TTM) | $69.21M |
| Net Income | $-61.98M |
| Gross Margin | 0.00% |
3 analysts cover ENTA: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $19.67.